BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36819545)

  • 1. The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study.
    Zheng Z; Yuan X; Zhou Y; Chu L; Yang X; Ni J; Chu Q; Chu X; Liu Y; Zhu Z
    Ann Transl Med; 2023 Jan; 11(2):60. PubMed ID: 36819545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
    Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
    Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
    Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
    Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer.
    Xie Z; Liu J; Wu M; Wang X; Lu Y; Han C; Cong L; Li J; Meng X
    J Clin Med; 2023 Jun; 12(11):. PubMed ID: 37298023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
    Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
    Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer.
    Peng J; Zhang L; Wang L; Feng H; Yao D; Meng R; Liu X; Li X; Liu N; Tan B; Huang Z; Li S; Meng X
    Radiat Oncol; 2023 Jul; 18(1):111. PubMed ID: 37403111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
    Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
    Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
    Yao Y; Li B; Song R; Yang L; Zou B; Wang L
    Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
    Han J; Fu C; Li B
    Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
    Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
    Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis.
    Qi J; Xu L; Sun J; Wang X; Zhao L
    Cancer Manag Res; 2019; 11():10767-10775. PubMed ID: 31920386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.
    Luan Z; Wang Z; Huang W; Zhang J; Dong W; Zhang W; Li B; Zhou T; Li H; Zhang Z; Wang Z; Sun H; Yi Y
    Exp Ther Med; 2015 Aug; 10(2):671-678. PubMed ID: 26622373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell Lung Cancer: Implications for Thoracic Radiotherapy.
    Kim D; Kim HJ; Wu HG; Lee JH; Kim S; Kim TM; Kim JS; Kim BH
    Cancer Res Treat; 2024 Apr; 56(2):430-441. PubMed ID: 37933113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center.
    Li Y; Jing W; Jing X; Sun Y; Tang X; Guo J; Zhang Y; Zhu H
    Discov Oncol; 2023 May; 14(1):55. PubMed ID: 37142872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis.
    Cai Z; Gu X; Xie J; Cheng D; Chen J; Cheng J; Ye J; Lv T
    Transl Lung Cancer Res; 2023 Oct; 12(10):1987-2000. PubMed ID: 38025813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
    Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thoracic radiotherapy in extensive stage small cell lung cancer: a systemic review and meta-analysis.
    Li AM; Zhou H; Xu YY; Ji XQ; Wu TC; Yuan X; Jiang CC; Zhu XX; Zhan P; Shen ZT
    Ann Transl Med; 2021 Feb; 9(4):299. PubMed ID: 33708926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy.
    Yuan X; Zheng Z; Liu F; Gao Y; Zhang W; Berardi R; Mohindra P; Zhu Z; Lin J; Chu Q
    Transl Lung Cancer Res; 2021 May; 10(5):2163-2171. PubMed ID: 34164267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
    Slotman BJ; Faivre-Finn C; van Tinteren H; Keijser A; Praag J; Knegjens J; Hatton M; van Dam I; van der Leest A; Reymen B; Stigt J; Haslett K; Tripathi D; Smit EF; Senan S
    Lung Cancer; 2017 Jun; 108():150-153. PubMed ID: 28625628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.